These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8368635)

  • 1. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis.
    Ellard GA; Humphries MJ; Allen BW
    Am Rev Respir Dis; 1993 Sep; 148(3):650-5. PubMed ID: 8368635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis.
    Kaojarern S; Supmonchai K; Phuapradit P; Mokkhavesa C; Krittiyanunt S
    Clin Pharmacol Ther; 1991 Jan; 49(1):6-12. PubMed ID: 1988241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children.
    Donald PR
    Tuberculosis (Edinb); 2010 Sep; 90(5):279-92. PubMed ID: 20709598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.
    Pouplin T; Bang ND; Toi PV; Phuong PN; Dung NH; Duong TN; Caws M; Thwaites GE; Tarning J; Day JN
    BMC Infect Dis; 2016 Apr; 16():144. PubMed ID: 27039088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid isoniazid concentrations in children with tuberculous meningitis: the influence of dosage and acetylation status.
    Donald PR; Gent WL; Seifart HI; Lamprecht JH; Parkin DP
    Pediatrics; 1992 Feb; 89(2):247-50. PubMed ID: 1734391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An adult case of tuberculous meningitis].
    Nakao S; Matsumoto H; Fujiuchi S; Takahashi M; Sato K; Takeda A; Okamoto K; Fujita Y; Yamazaki Y; Fujikane T; Yahara O; Shimizu T
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):294-9. PubMed ID: 12795185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of tuberculous meningitis: role of short-course chemotherapy.
    Phuapradit P; Vejjajiva A
    Q J Med; 1987 Mar; 62(239):249-58. PubMed ID: 3659258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children.
    Savic RM; Ruslami R; Hibma JE; Hesseling A; Ramachandran G; Ganiem AR; Swaminathan S; McIlleron H; Gupta A; Thakur K; van Crevel R; Aarnoutse R; Dooley KE
    Clin Pharmacol Ther; 2015 Dec; 98(6):622-9. PubMed ID: 26260983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the treatment of adult tuberculous meningitis].
    Yu BZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):79-80, 126. PubMed ID: 1394596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemotherapy of tuberculous meningitis in children and adults.
    Donald PR
    Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of isoniazid transfer into cerebrospinal fluid in patients with tuberculous meningitis.
    Shin SG; Roh JK; Lee NS; Shin JG; Jang IJ; Park CW; Myung HJ
    J Korean Med Sci; 1990 Mar; 5(1):39-45. PubMed ID: 2206465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of refractory tuberculous meningitis markedly improved by intrathecal administration of isoniazid (INH)].
    Takahashi T; Ogawa K; Sawada S; Nakayama T; Mizutani T
    Rinsho Shinkeigaku; 2003; 43(1-2):20-5. PubMed ID: 12820546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculous meningitis: is a 6-month treatment regimen sufficient?
    van Loenhout-Rooyackers JH; Keyser A; Laheij RJ; Verbeek AL; van der Meer JW
    Int J Tuberc Lung Dis; 2001 Nov; 5(11):1028-35. PubMed ID: 11716339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three chemotherapy studies of tuberculous meningitis in children.
    Ramachandran P; Duraipandian M; Nagarajan M; Prabhakar R; Ramakrishnan CV; Tripathy SP
    Tubercle; 1986 Mar; 67(1):17-29. PubMed ID: 3715980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis.
    Mezochow A; Thakur KT; Zentner I; Subbian S; Kagan L; Vinnard C
    Int J Infect Dis; 2019 Jul; 84():15-21. PubMed ID: 31051278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Treatment of tuberculous meningitis.
    Lancet; 1976 Apr; 1(7963):787-8. PubMed ID: 56598
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of intractable tuberculous meningitis using intrathecal isoniazid administration and steroid pulse therapy; a report of two cases].
    Takahashi I; Yamada M; Matsushima M; Sato K; Kano T; Yabe I; Sasaki H
    Rinsho Shinkeigaku; 2012; 52(8):551-6. PubMed ID: 22975852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.